[GLP-1 derivatives, for the prevention and treatment of type 2 diabetes mellitus]

Nihon Shokakibyo Gakkai Zasshi. 2005 Nov;102(11):1398-404.
[Article in Japanese]
No abstract available

MeSH terms

  • Animals
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Diabetes Mellitus, Type 2 / physiopathology
  • Diabetes Mellitus, Type 2 / prevention & control*
  • Dogs
  • Exenatide
  • Glucagon-Like Peptide 1 / physiology
  • Glucagon-Like Peptide 1 / therapeutic use*
  • Humans
  • Insulin / metabolism
  • Insulin Secretion
  • Metabolic Syndrome / complications
  • Obesity / metabolism
  • Peptides / therapeutic use
  • Venoms / therapeutic use

Substances

  • Insulin
  • Peptides
  • Venoms
  • Glucagon-Like Peptide 1
  • Exenatide